Coming Soon – New Scientific Data Sharing Website

March 10, 2022

If you’re working on NIH-funded research, you probably know the new NIH Data Management and Sharing (DMS) Policy goes into effect January 25, 2023. Don’t worry — there are several resources in the works to help you prepare! In April we are launching a new NIH Scientific Data Sharing website, a one-stop shop for all the information you need to know about NIH sharing policies.   

Designing Analyses by Sex or Gender, Race, and Ethnicity in NIH-defined Phase 3 Clinical Trials

March 10, 2022

NIH-defined phase 3 clinical trials are required to conduct and report analyses by sex or gender, race, and ethnicity for each primary outcome. These analyses, referred to as “valid analyses” are unbiased assessments that on average, yield the correct estimate of the difference in outcomes between two groups of participants.

Updated Resources for Registration in eRA Commons

March 9, 2022

Simplified wizard-like screens will greet signing officials who are completing the one-time registration for their organization in eRA Commons. The updated Registration screens accommodate SAM-issued Unique Entity Identifiers (UEIs) and will pre-populate institutional information based on available active registration data in

Check Your Application for Completeness Before Submitting

March 9, 2022

We really care about the details. It is important to a fair review that all applicants competing together for funding have adhered to the same rules. It is also important that your application is submitted in a way that allows us to efficiently process your application and make it available for funding consideration. Consequently, your application will be checked at, by our eRA systems and finally by our staff before it is referred for review.

Notice of Change to NIH’s Policy on Special Council Review of Research Applications

February 24, 2022

NIH recently announced an update to the Special Council Review (SCR) policy to align with updated Other Support disclosure requirements. Effective with the FY 2022 May/June Council round, Advisory Council members will continue to provide additional consideration of new and renewal applications from well-supported investigators who currently receive $2 million or more in total costs, per year of active NIH funding.